Table 2.
Location | Study Number | % of Total (N = 90) |
---|---|---|
Single‐country studies | 85 | 94 |
North America | 46 | 51 |
USA | 34 | 38 |
Canada | 10 | 11 |
Dominican Republic | 2 | 2.2 |
Europe | 26 | 29 |
Netherlands | 6 | 6.7 |
UK | 5 | 5.6 |
Spain | 4 | 4.4 |
Sweden | 4 | 4.4 |
Belgium | 2 | 2.2 |
Germany | 2 | 2.2 |
Switzerland | 2 | 2.2 |
France | 1 | 1.1 |
Asia | 10 | 11 |
Japan | 4 | 4.4 |
South Korea | 2 | 2.2 |
India | 1 | 1.1 |
Iran | 1 | 1.1 |
Israel | 1 | 1.1 |
Turkey | 1 | 1.1 |
Australia | 3 | 3.3 |
Australia | 3 | 3.3 |
Multiple‐Country Studies | 5 | 5.6 |
EUROHIPa | 2 | 2.2 |
89 Country Studyb | 1 | 1.1 |
USA, Canada | 1 | 1.1 |
USA, UK, Australia | 1 | 1.1 |
aEUROHIP Cohort: Austria, Switzerland, Germany, Hungary, Poland, Spain, Italy, France, Sweden, Iceland, Finland, UK. bStudy included countries from six continents: North America, South America, Europe, Asia, Africa, Australia.